about
Stenting for malignant ureteral obstruction: Tandem, metal or metal-mesh stentsEndoscopic management of renal lymphangioma: a case report.Advanced therapy for prostatitis: minimally invasive and invasive therapies.Digital ureteroscopy: the next step.Encrusted urinary stents: evaluation and endourologic management.Lasers in percutaneous renal procedures.Laparoscopic heminephrectomy for benign disease of the horseshoe kidneyThe endourological management of complications associated with horseshoe kidney.Hand-assisted laparoscopic renal surgery: current trends and applications.Correlation of ureteroscopic appearance with histologic grade of upper tract transitional cell carcinoma.Ureteropelvic junction obstruction repair: when, how, what?Association of estimated glomerular filtration rate with 24-h urinalysis and stone composition.Percutaneous renal access: tips and tricks.Renal pelvic stones: choosing shock wave lithotripsy or percutaneous nephrolithotomy.Laparoscopic port site metastases: incidence, risk factors, and potential preventive measures.Endourologic treatment of upper urinary tract transitional cell carcinoma.Crossing vessels are not important in the etiology of ureteropelvic junction obstruction.Laparoscopic versus open radical nephrectomy for xanthogranulomatous pyelonephritis: Contemporary outcomes analysis.Pelvic kidney: associated diseases and treatment.Bladder Necrosis Associated with Placenta Accreta, Embolization, and Repair of CystotomiesUrinary tract infections and post-operative fever in percutaneous nephrolithotomy.Conservative Management of Combined Pleural and Splenic Injury During Percutaneous Nephrostolithotomy.Bacillus Calmette-Guérin for upper tract urothelial cancer: is there a role?Management of hemorrhagic complications associated with percutaneous nephrolithotomy.Renal drainage after percutaneous nephrolithotomy.The debate over percutaneous nephrolithotomy positioning: a comprehensive review.Management of urolithiasis in patients after urinary diversions.Obstructive uropathy from locally advanced and metastatic prostate cancer: an old problem with new therapies.Live surgical demonstrations: an old, but increasingly controversial practice.Using 24-hour urinalysis to predict stone type.Differences in 24-hour urine composition between apatite and brushite stone formers.Calyceal diverticula: a comprehensive review.Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus.Comparison of the metabolic profile of mixed calcium oxalate/uric acid stone formers to that of pure calcium oxalate and pure uric acid stone formers.Association of serum biochemical metabolic panel with stone composition.Continuing aspirin therapy during percutaneous nephrolithotomy: unsafe or under-utilized?Contemporary assessment of renal stone complexity using cross-sectional imaging.Does hypertension impact 24-hour urine parameters in patients with nephrolithiasis?Percutaneous nephrolithotomy in super obese patients (body mass index ≥ 50 kg/m²): overcoming the challenges.Predictive factors for intraoperative balloon dilation in semirigid ureteroscopic lithotripsy.
P50
Q28086873-5BD536C3-A352-4362-A31E-507388D16B66Q30832874-78C27124-5258-4B7C-92BD-5C54EA9D89A1Q30969724-743B004D-22F5-49DB-86BD-6C4077BDCC87Q33328928-636E07EB-DB09-45CD-84A5-6D96D366F2A6Q33353565-85B4B5AB-EA92-485C-A09B-F2170141A7F2Q33458451-1EEFACBA-F846-4589-9A89-8A060BA93B12Q34596248-29F5396E-2D0D-4934-8097-A33C54585F55Q34671833-79E50DB4-F445-4B43-9EC7-FBCBF6174C32Q34839335-CEE16385-8535-4E14-AE96-5CB03D10BFABQ35741535-A5AA254C-3ECD-47E2-9D83-72D662FB9A51Q35742683-A2C2CC9B-D389-4EAD-85E0-E4110AD15C99Q35843164-C88AB66C-66DD-44BD-AE6D-74C25BAEA3BDQ36048532-6D9E45D2-B63B-470E-BDF4-0A637178183CQ36060869-56CD8467-5C3A-4128-AFE8-9F70E0CDF453Q36099767-1548187C-BA97-4A23-A0E5-A0E6A66C17CBQ36395132-97CD9154-A0AE-4D3F-8C7A-3F97DF4350E9Q36646753-04832757-2D77-49BA-ABD8-14EE8541EF56Q36722385-0691EC7B-75B0-46EC-946B-D475EEA7544CQ36941865-DA69795F-66FD-4B74-8DA1-E1046495EE00Q37201187-33151F42-A006-4654-A270-78CCA586ADAFQ37203769-8D683778-5A89-476E-A615-A56FF5BD8827Q37411431-168B10E2-9D73-424E-8DC1-3B001FC9073AQ37427774-DB75B82C-A8BB-41FA-8A22-FA9C0BD23CC6Q37595498-9B0EC552-9C71-431E-87F9-822F9E657747Q37605838-84523935-C85E-4A66-851C-FB5F80D8BEABQ37875506-F7D30B06-14AA-4B82-92E2-97CE3134E5B3Q37880235-835DB820-D8E6-4B60-8A0F-033D4C8DAB47Q37970778-FA229962-90DA-4ED7-9B56-056C84D155CCQ37988145-9BA2A654-37CF-4113-B735-E19862A18F95Q38114230-A5A725E1-295D-461E-9A9C-B2C5A3C6B960Q38116205-F42C394F-FD27-403B-BEAD-A0C49D1A1F63Q38208862-266C6A67-3C21-4CE2-814B-603D3BFBFBE3Q38211455-56E4703F-7DE4-48D8-A54A-F0B6D1B1DFF6Q38220295-2B20C2F2-49EF-48A1-87DE-9F3A4FB2A261Q38254465-B8EC23DD-5908-4540-8B2B-93841192D796Q38267860-732D1966-224D-441C-B2DE-C16F6A6E01C8Q38359521-66ECF91F-9538-42F8-AD83-26181CBD0F5FQ38367056-8FA183DE-3125-4B24-8C65-B2355F8862A3Q38428810-2FFB9CD4-FD6B-426B-ADF0-B8B06B8BA1B2Q38434386-5A89FB99-6472-4649-8E71-2F79A60D5C81
P50
description
onderzoeker
@nl
name
Arthur D Smith
@ast
Arthur D Smith
@en
Arthur D Smith
@es
Arthur D Smith
@nl
type
label
Arthur D Smith
@ast
Arthur D Smith
@en
Arthur D Smith
@es
Arthur D Smith
@nl
prefLabel
Arthur D Smith
@ast
Arthur D Smith
@en
Arthur D Smith
@es
Arthur D Smith
@nl